SynopsisThe global market for Oncaspar was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 281 million by 2031, growing at a CAGR of 11.4% during the forecast period. Oncaspar is a cancer medicine used in adults and chi.....
SynopsisThe global market for Digoxin was valued at US$ 63.8 million in the year 2024 and is projected to reach a revised size of US$ 78.7 million by 2031, growing at a CAGR of 3.1% during the forecast period. Digoxin is a cardiac glycoside extracted from the le.....
SynopsisThe global market for Therapeutic Enzymes was valued at US$ 9390 million in the year 2024 and is projected to reach a revised size of US$ 20660 million by 2031, growing at a CAGR of 12.1% during the forecast period. Therapeutic enzymes have a broad varie.....
SynopsisThe global market for Cancer Respiratory Biopsy was valued at US$ 350 million in the year 2024 and is projected to reach a revised size of US$ 1251 million by 2031, growing at a CAGR of 20.0% during the forecast period. Cancer respiratory biopsy is a non.....
SynopsisThe global market for Recombinant Human Glial Cell Maturation Factor β was valued at US$ 104 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.5% during the forecast period. GMF-beta belo.....
SynopsisThe global market for Transcatheter Mitral Valve Replacement (TMVR) was valued at US$ 1881 million in the year 2024 and is projected to reach a revised size of US$ 10190 million by 2031, growing at a CAGR of 27.7% during the forecast period. TMVR, also k.....
SynopsisThe global market for Neonatal (Preterm) Infant Care was valued at US$ 2523 million in the year 2024 and is projected to reach a revised size of US$ 3675 million by 2031, growing at a CAGR of 5.6% during the forecast period. Neonatal (preterm) infant car.....
SynopsisThe global market for Temporary Cardiac Pacing Leads was valued at US$ 171 million in the year 2024 and is projected to reach a revised size of US$ 251 million by 2031, growing at a CAGR of 5.7% during the forecast period. The temporary pacing lead, a sm.....
SynopsisThe global market for Rapid Influenza Diagnostic Test (RIDT) was valued at US$ 1053 million in the year 2024 and is projected to reach a revised size of US$ 2025 million by 2031, growing at a CAGR of 9.9% during the forecast period. In China, the key pla.....
SynopsisThe global market for Mobile Medical Care Workstation was valued at US$ 1072 million in the year 2024 and is projected to reach a revised size of US$ 1521 million by 2031, growing at a CAGR of 5.2% during the forecast period. Mobile medical care workstat.....
